Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Status:
Completed
Trial end date:
2017-10-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the long-term effectiveness and safety of
CP-690,550 for the treatment of rheumatoid arthritis. Subjects are eligible for this study
only after participating in another "qualifying" study of CP-690,550
A sub-study will be conducted within the A3921024 study, this study will evaluate the immune
response to pneumococcal and influenza vaccines in patients receiving CP-690,550